CD3-ε overexpressed in prothymocytes acts as an oncogene

Molecular Medicine

Volumn 3, Issue 1, 1997, Pages 72-81

  Wang, Baoping ^a,e   She, Jian ^a   Salio, Mariolina ^a,c   Allen, Deborah ^a   Lacy, Elizabeth ^b   Lonberg, Nils ^b,d   Terhorst, Cox ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^d GenPharm International   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; T LYMPHOCYTE RECEPTOR; DNA BINDING PROTEIN; PROTEIN; PROTEIN KINASE LCK; PROTEIN TYROSINE KINASE; RAG2 PROTEIN, MOUSE; V(D)J RECOMBINATION ACTIVATING PROTEIN 2;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CARCINOGENESIS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL; T LYMPHOCYTE; THYMOCYTE; THYMUS LYMPHOMA; TRANSGENIC MOUSE; ANIMAL; CELL DEATH; CYTOLOGY; CYTOPLASM; GENETICS; GROWTH, DEVELOPMENT AND AGING; LYMPH NODE; PATHOLOGY; PHYSIOLOGY; SPLEEN; T CELL LYMPHOMA; THYMOMA; THYMUS;

ANIMALS; ANTIGENS, CD3; CELL DEATH; CYTOPLASM; DNA-BINDING PROTEINS; LYMPH NODES; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); LYMPHOMA, T-CELL; MICE; MICE, TRANSGENIC; ONCOGENES; PROTEINS; SIGNAL TRANSDUCTION; SPLEEN; SRC-FAMILY KINASES; T-LYMPHOCYTES; THYMOMA; THYMUS GLAND;

EID: 0030614837     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401669     Document Type: Article

References (42)

1. Korsmeyer SJ. (1993) Programed cell death: BcI-2. Important Adv. Oncol. 93: 19-28.
2. Vogelstein B, Kinzler KW. (1993) The multistep nature of cancer. Trends Genet. 9: 138-141.
3. Boettiger D. (1989) Interaction of oncogenes with differentiation programs. Curr. Top. Microbiol. Immunol. 147: 31-78.
4. Hall M, Peters G. (1996) Genetic alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancer. Adv. Cancer Res. 68: 67-109.
5. Selivanova G, Wiman KG. (1995) p53: A cell cycle regulator activated by DNA damage. Adv. Cancer Res. 66: 143-180.
6. Leonard CJ, Canman CE, Kastan MB. (1995) The role of p53 in cell-cycle control and apoptosis: Implications for cancer. Important Adv. Oncol. 95: 33-42.
7. Wang JY, Knudsen ES, Welch PJ. (1994) The retinoblastoma tumor suppressor protein. Adv. Cancer Res. 64: 25-85.
8. Fisher RJ, Bader JP, Papas TS. (1989) Oncogenes and the mitogenic signal pathway. Important Adv. Oncol. 89: 3-27.
9. Balmain A, Brown K. (1988) Oncogene activation in chemical carcinogenesis. Adv. Cancer Res. 51: 147-182.
10. Dilworth SM, Brewster CE, Jones MD, Lanfrancone L, Pelicci G, Pelicci PG. (1994) Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc. Nature 367: 87-90.
11. Crowe AJ, McGlade J, Pawson T, Hayman MJ. (1994) Phosphorylation of the SHC proteins on tyrosine correlates with the transformation of fibroblasts and erythroblasts by the v-sea tyrosine kinase. Oncogene 9: 537-544.
12. Harrison-Pindik D, Susa M, Varticovski L. (1995) Association of phosphatidylinositol 3-kinase with SHC in chronic myelogeneous leukemia cells. Oncogene 10: 1385-1391.
13. Pelicci G, Lanfrancone L, Grignani F, McGlade J, Cavallo F, Forni G, Nicoletti I, Grignani F, Pawson T, Pelicci PG. (1992) A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70: 93-104.
14. Pelicci G, Lanfrancone L, Salcini AE, Romano A, Mele S, Grazia Borrello M, Segatto O, Di Fiore PP, Pelicci PG. (1995) Constitutive phosphorylation of Shc proteins in human tumors. Oncogene 11: 899-907.
15. Salcini AE, McGlade J, Pelicci G, Nicoletti I, Pawson T, Pelicci PG. (1994) Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Oncogene 9: 2827-2836.
16. Clevers H, Alarcon B, Wilwman T, Terhorst C. (1988) The T cell receptor/CD3 complex: A dynamic protein ensembe. Annu. Rev. Immunol. 6: 629-662.
17. Ashwell JD, Klusner RD. (1990) Genetic and mutational analysis of the T-cell antigen receptor. Annu. Rev. Immunol. 8: 139-167.
18. Letourneur F, Klausner RD. (1992) Activation of T cells by a tyrosine kinase activation domain in the cytoplasmic tail of CD3 ε. Science 255: 79-82.
19. Wegener A-MK, Letourneur F, Hoeveler A, Brocker T, Luton F, Malissen B. (1992) The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules. Cell 68: 83-95.
20. Terhorst C, Regueiro JR. (1992) T cell activation. In: Lachmann PJ et al. (eds) Clinical Aspects of Immunology Blackwell Science, Inc. Oxford, UK. Vo1 1, pp. 447-466.
21. Owen JJT, Owen MJ, Williams GT, Kingston R, Jenkinson EJ. (1988) The effects of anti-CD3 antibodies on the development T-cell receptor αβ lymphocytes in embryonic thymus organ cultures. Immunology 63: 639-642.
22. Bentin J, Vaughan JH, Tsoukas CD. (1988) T cell proliferation induced by anti-CD3 antibodies: Requirement for a T-T cell interaction. Eur. J. Immunol. 18: 627-632.
23. Levelt CN, Mombaerts P, Wang B, Kohler H, Tonegawa S, Eichmann K, Terhorst C. (1995) Regulation of thymocyte development through CD3: Functional dissociation between p56lck and CD3 sigma in early thymic selection. Immunity 3: 215-222.
24. Malissen M, Gillet A, Ardouin L, Bouvier G, Trucy J, Ferrier P, Vivier E, Malissen B. (1995) Altered T cell development in mice with a targeted mutation of the CD3-ε gene. EMBO J. 14: 4641-4653.
25. Shinkai Y, Ma A, Cheng HL, Alt FW. (1995) CD3 epsilon and CD3 zeta cytoplasmic domains can independently generate signals for T cell development and function. Immunity 2: 401-411.
26. ck. Proc. Natl. Acad. Sci. U.S.A. 88: 3977-3981.
27. Anderson SJ, Levin SD, Perlmutter RM. (1994) Involvement of the protein tyrosine kinase p56lck in T cell signaling and thymocyte development. Adv. Immunol. 56: 151-178.
28. Wang B, Biron C, She J, Higgins K, Sunshine MJ, Lacy E, Lonberg N, Terhorst C. (1994) A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene. Proc. Natl. Acad. Sci. U.S.A. 91: 9402-9406.
29. Wang B, Levelt CN, Salio M, Zheng D-X, Sancho J, Liu C-P, She J, Huang M, Higgins K, Sunshine M-J, Eichmann K, Lacy L, Lonberg N, Terhorst C. (1995) Over-expression of CD3ε transgenes blocks T lymphocyte development. Int. Immunol. 7: 435-448.
30. Molina TJ, Kishihara K, Siderovski DP, et al. (1992) Profound block in thymocyte development in mice lacking p56lck. Nature 357: 161-164.
31. Levelt CN, Mombaerts P, Iglesias A, Tonegawa S, Eichmann K, (1993) Restoration of early thymocyte differentiation in T-cell receptor beta-chain-deficient mutant mice by transmembrane signaling through CD3 epsilon. Proc. Natl Acad. Sci. U.S.A. 90: 11401-11405.
32. Shinkai Y, Rathbun G, Lam K-P, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM, Alt FW. (1992) Rag-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68: 855-867.
33. Godfrey DI, Zlotnik A. (1993) Control points in early T-cell development. Immunol. Today 14: 547-553.
34. Scollay R, Wilson A, D'Amico A, Kelly K, Egerton M, Pearse M, Wu L, Shortman K. (1988) Developmental status and reconstitution potential of subpopulations of murine thymocytes. Immunol. Rev. 104: 81-120.
35. Shinkai Y, Alt FW. (1994) CD3 epsilon-mediated signals rescue the development of CD4+CD8+ thymocytes in RAG-2-/- mice in the absence of TCR beta chain expression. Int. Immunol. 6: 995-1001.
36. Levelt CN, Wang B, Ehrfeld A, Terhorst C, Eichmann K. (1995) Regulation of T cell receptor (TCR)-beta locus allelic exclusion and initiation of TCR-alpha locus rearrangement in immature thymocytes by signaling through the CD3 complex. Eur. J. Immunol. 25: 1257-1261.
37. Dedera DA, Waller EK, LeBrun DP, Sen-Majumdar A, Stevens ME, Barsh GS, Cleary ML. (1993) Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice. Cell 74: 833-843.
38. Winandy S, Wu P, Georgopoulos K. (1995) A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83: 289-299.
39. O'Neill HC, McGrath MS, Allison JP, Weissman IL. (1987) A subset of T cell receptors associated with L3T4 molecules mediates C6VL leukemia cell binding of its cognate retrovirus. Cell 49: 143-151.
40. McGrath MS, Pillemer E, Weissman IL. (1980) Murine leukaemogenesis: Monoclonal antibodies to T-cell determinants arrest T-lymphoma cell proliferation. Nature 285: 259-261.
41. Anderson SJ, Perlmutter RM. (1995) A signaling pathway governing early thymocyte maturation. Immunol. Today 16: 99-105.
42. Weiss A, Littman DR. (1994) Signal transduction by lymphocyte antigen receptors. Cell 76: 263-274.